A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy. ...
May 6, 2014
A UCLA neurosurgeon was part of a prestigious task force that has created a new clinical definition for epilepsy. The new interpretation, which updates a definition that had been in use for nearly a decade, broadens the scope ...
May 6, 2014
New cancer therapies, particularly agents that block vascular endothelial growth factor (VEGF) signaling, have improved the outlook for patients with some cancers and are now used as a first line therapy for some tumors. ...
May 6, 2014
(Medical Xpress)—An antioxidant that targets specific cell structures—mitochondria—may be able to reverse some of the negative effects of aging on arteries, reducing the risk of heart disease, according to a new study ...
May 6, 2014
